Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 4, Issue 2, Page 10 (February 2008)


View previous. 11 of 37 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (60 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

Officials Mull Action in Light of New Vytorin Data

ALICIA AULT (Associate Editor, Practice Trends)

The Food and Drug Administration said that it is considering, but has not determined yet, whether data from the ENHANCE study of Vytorin warrants any regulatory action.

PII: S1553-3212(08)70069-4

doi:10.1016/S1553-3212(08)70069-4


View previous. 11 of 37 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.